Abstract:Background:Fetal structural anomalies are detected by ultrasound in approximately 3 % of pregnancies. Numerous genetic diagnostic strategies have been widely applied to identify the genetic causes of prenatal abnormalities. We aimed to assess the value of simultaneous copy number variation sequencing (CNV-seq) and whole exome sequencing (WES) in diagnosing fetuses with structural anomalies. Methods:Fetuses with structural anomalies detected by ultrasound were included for eligibility. After genetic counseling, WES and CNV-seq were performed on DNA samples of fetuses and their parents. All detected variants were evaluated for pathogenicity according to ACMG criteria, with the final diagnosis was determined based on ultrasound results and relevant family history. Results:The diagnostic rate of 174 fetuses with prenatal ultrasound abnormalities was 26.44 %, higher than that achieved through either CNV or WES analysis alone. Furthermore, the highest diagnostic rate was observed in fetuses with multiple system anomalies, accounting for 50 % of the total diagnostic yield, followed by skeletal system anomalies at 45.45 %. Three cases with multiple system abnormalities were found to have a dual diagnosis of pathogenic CNVs and SNV variants, representing 1.72 % of the total cohort. 38 pregnant women in their third trimester of pregnancy (27 weeks+) participated in this study, and 23.68 % received a confirmed genetic diagnosis. Finally, 31 women (67.39 %) voluntarily terminated their pregnancy following the testing and extensive genetic counseling. Conclusions:Our study demonstrated that the simultaneous CNV-seq and WES analyses are beneficial for the molecular diagnosis of underlying unexplained structural anomalies in fetuses. This strategy is more efficient in elucidating prenatal abnormalities with compound problems, such as dual diagnoses. Furthermore, the simultaneous strategy has a shorter turnaround time and is particularly suitable for families with structural anomalies found in the third trimester of pregnancy.

Additional File 3 of Clinical Efficiency of Simultaneous CNV-seq and Whole-Exome Sequencing for Testing Fetal Structural Anomalies

Clinical efficiency of simultaneous CNV-seq and whole-exome sequencing for testing fetal structural anomalies

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

Simultaneous CNV-seq and WES: an Effective Strategy for Molecular Diagnosis of Unexplained Fetal Structural Anomalies

A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing.

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing

Simultaneous Detection of CNVs and SNVs Improves the Diagnostic Yield of Fetuses with Ultrasound Anomalies and Normal Karyotypes

Prospective Prenatal Cell-Free DNA Screening for Genetic Conditions of Heterogenous Etiologies

Clinical Application of Medical Exome Sequencing for Prenatal Diagnosis of Fetal Structural Anomalies.

Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder

Prenatal exome sequencing in fetuses with callosal anomalies

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Diagnostic Yield of Whole Exome Data in Fetuses Aborted for Conotruncal Malformations

Comprehensive genome sequencing analysis as a promising option in the prenatal diagnosis of fetal structural anomalies: a prospective study

Application of exome sequencing for prenatal diagnosis of fetal structural anomalies: clinical experience and lessons learned from a cohort of 1618 fetuses

Additional File 4 of the Diagnostic Yield of Intellectual Disability: Combined Whole Genome Low-Coverage Sequencing and Medical Exome Sequencing

High positive predictive value of CNVs detected by clinical exome sequencing in suspected genetic diseases

Exome sequencing improves genetic diagnosis of fetal increased nuchal translucency

The Value of a Comprehensive Genomic Evaluation in Prenatal Diagnosis of Genetic Diseases: A Retrospective Study

Efficiency of copy number variation sequencing combined with karyotyping in fetuses with congenital heart disease and the following outcomes